-
公开(公告)号:US20060199795A1
公开(公告)日:2006-09-07
申请号:US10543997
申请日:2004-01-27
申请人: Fumio Itoh , Shuji Hinuma , Naoyuki Kanzaki , Takashi Miki , Yuji Kawamata , Satoru Oi , Taisuke Tawaraishi , Yuji Ishichi , Mariko Hirohashi
发明人: Fumio Itoh , Shuji Hinuma , Naoyuki Kanzaki , Takashi Miki , Yuji Kawamata , Satoru Oi , Taisuke Tawaraishi , Yuji Ishichi , Mariko Hirohashi
IPC分类号: A61K31/554 , A61K31/553 , A61K31/5513
CPC分类号: C07D267/14 , A61K31/4353 , A61K31/5513 , A61K31/553
摘要: The present invention provides a TGR5 receptor agonist comprising a fused ring compound represented by the formula wherein ring A is an optionally substituted aromatic ring; and ring B′ is a 5- to 8-membered ring having one or more substituents or a salt thereof or a prodrug thereof, which is useful for the treatment of various diseases.
摘要翻译: 本发明提供一种TGR5受体激动剂,其包含由下式表示的稠环化合物:其中环A为任选取代的芳环; 环B'是具有一个或多个取代基的5-至8-元环或其盐或其前药,其可用于治疗各种疾病。
-
公开(公告)号:US07625887B2
公开(公告)日:2009-12-01
申请号:US10543997
申请日:2004-01-27
申请人: Fumio Itoh , Shuji Hinuma , Naoyuki Kanzaki , Yuji Kawamata , Taisuke Tawaraishi , Yuji Ishichi , Mariko Hirohashi
发明人: Fumio Itoh , Shuji Hinuma , Naoyuki Kanzaki , Yuji Kawamata , Taisuke Tawaraishi , Yuji Ishichi , Mariko Hirohashi
IPC分类号: A61K31/553 , A61K45/00 , C07D267/22 , C07D281/02
CPC分类号: C07D267/14 , A61K31/4353 , A61K31/5513 , A61K31/553
摘要: It is intended to provide a TGR5 receptor agonist containing a fused ring compound represented by the following general formula, its salt or a prodrug thereof: (1) wherein ring A represents an optionally substituted aromatic ring; and the ring B′ represents a 5- to 8-membered ring having one or more substituents; which is useful in treating various diseases.
摘要翻译: 本发明提供一种TGR5受体激动剂,其含有下述通式表示的稠环化合物,其盐或其前药:(1)其中环A表示任选取代的芳环; 环B'表示具有一个或多个取代基的5-至8-元环; 其用于治疗各种疾病。
-
公开(公告)号:US20070117840A1
公开(公告)日:2007-05-24
申请号:US10549889
申请日:2004-03-16
申请人: Fumio Itoh , Shuji Hinuma , Naoyuki Kanzaki , Yoshihiro Banno , Hiromi Yoshida , Hirokazu Matsumoto
发明人: Fumio Itoh , Shuji Hinuma , Naoyuki Kanzaki , Yoshihiro Banno , Hiromi Yoshida , Hirokazu Matsumoto
IPC分类号: A61K31/4704
CPC分类号: A61K31/4704
摘要: A compound represented by the formula (I): wherein ring A represents an aromatic ring; X represents a bond, oxygen, NR4 (R4 represents hydrogen, a hydrocarbon group, or a heterocyclic group), or alkylene; R1 represents a hydrocarbon group, or a heterocyclic group; R2 represents —COYR5 (Y represents a bond, alkylene, oxygen, sulfur, or NR6 (R6 represents hydrogen, a hydrocarbon group, or a heterocyclic group), and R5 represents a hydrocarbon group, or a heterocyclic group), a hydrocarbon group, or a heterocyclic group; and R3 represents a hydrocarbon group, a heterocyclic group, optionally substituted hydroxy, optionally substituted amino, or —S(O)nR7 (R7 represents a hydrocarbon group, or a heterocyclic group, and n is 0 to 2), a salt of the compound, or a prodrug or either is useful as an agent for modulating the function of an RFRP receptor.
摘要翻译: 由式(I)表示的化合物:其中环A表示芳环; X表示键,氧,NR 4(R 4表示氢,烃基或杂环基)或亚烷基; R 1表示烃基或杂环基; R 2表示-COYR 5(Y表示键,亚烷基,氧,硫或NR 6(R 6) SUP>表示氢,烃基或杂环基),R 5表示烃基或杂环基),烃基或杂环基; 和R 3表示烃基,杂环基,任选取代的羟基,任选取代的氨基或-S(O)n R 7 (R 7表示烃基或杂环基,n为0〜2),化合物或前药的盐或其可用作调节其功能的试剂 RFRP受体。
-
公开(公告)号:US20090239839A1
公开(公告)日:2009-09-24
申请号:US12391520
申请日:2009-02-24
申请人: Fumio ITOH , Shuji Hinuma , Naoyuki Kanzaki , Hiroshi Mabuchi , Hiromi Yoshida , Hirokazu Matsumoto , Takeshi Wakabayashi
发明人: Fumio ITOH , Shuji Hinuma , Naoyuki Kanzaki , Hiroshi Mabuchi , Hiromi Yoshida , Hirokazu Matsumoto , Takeshi Wakabayashi
IPC分类号: A61K31/553 , A61P25/04
CPC分类号: C07D267/08
摘要: An agent for modulating the function of an RFRP receptor, characterized by containing either a compound represented by the formula (I) [wherein ring A represents an optionally substituted aromatic ring; ring B represents an optionally substituted benzene ring; X represents oxygen, S(O)n (n is an integer of 0 to 2), or NR3 (R3 represents hydrogen, an optionally substituted hydrocarbon group, or an optionally substituted heterocyclic group); and R1 and R2 each represents hydrogen, an optionally substituted hydrocarbon group, or an optionally substituted heterocyclic group] or a salt of the compound.
摘要翻译: 用于调节RFRP受体功能的试剂,其特征在于含有由式(I)表示的化合物[其中环A表示任选取代的芳环; 环B表示任选取代的苯环; X表示氧,S(O)n(n为0〜2的整数)或NR 3(R 3表示氢,任选取代的烃基或任意取代的杂环基)。 并且R 1和R 2各自表示氢,任选取代的烃基或任选取代的杂环基]或该化合物的盐。
-
公开(公告)号:US20070129348A1
公开(公告)日:2007-06-07
申请号:US10553273
申请日:2004-04-15
申请人: Fumio Itoh , Shuji Hinuma , Naoyuki Kanzaki , Hiroshi Mabuchi , Hiromi Yoshida , Hirokazu Matsumoto , Takeshi Wakabayashi
发明人: Fumio Itoh , Shuji Hinuma , Naoyuki Kanzaki , Hiroshi Mabuchi , Hiromi Yoshida , Hirokazu Matsumoto , Takeshi Wakabayashi
IPC分类号: A61K31/554 , A61K31/553 , A61K31/5513
CPC分类号: C07D267/08
摘要: An agent for modulating the function of an RFRP receptor, characterized by containing either a compound represented by the formula (I) [wherein ring A represents an optionally substituted aromatic ring; ring B represents an optionally substituted benzene ring; X represents oxygen, S(O)n (n is an integer of 0 to 2), or NR3 (R3 represents hydrogen, an optionally substituted hydrocarbon group, or an optionally substituted heterocyclic group); and R1 and R2 each represents hydrogen, an optionally substituted hydrocarbon group, or an optionally substituted heterocyclic group] or a salt of the compound.
摘要翻译: 用于调节RFRP受体功能的试剂,其特征在于含有由式(I)表示的化合物[其中环A表示任选取代的芳环; 环B表示任选取代的苯环; X表示氧,S(O)n N(n为0〜2的整数)或NR 3(R 3)表示氢, 任选取代的烃基或任选取代的杂环基); 和R 1和R 2各自表示氢,任选取代的烃基或任选取代的杂环基]或该化合物的盐。
-
公开(公告)号:US20050197362A1
公开(公告)日:2005-09-08
申请号:US10935646
申请日:2004-09-08
申请人: Yuji Ishihara , Yuji Ishichi , Takayuki Doi , Hiroshi Nagabukuro , Naoyuki Kanzaki , Motoki Ikeuchi
发明人: Yuji Ishihara , Yuji Ishichi , Takayuki Doi , Hiroshi Nagabukuro , Naoyuki Kanzaki , Motoki Ikeuchi
IPC分类号: A61K31/00 , A61K31/138 , A61K31/40 , A61K31/445 , A61K31/473 , A61P13/00 , A61P13/08 , A61P43/00 , C07C233/41 , C07C311/07 , C07C311/08 , C07C311/37 , C07D209/08 , C07D209/14 , C07D209/48 , C07D211/32 , C07D215/22 , C07D215/227 , C07D217/04 , C07D217/06 , C07D217/08 , C07D223/16 , C07D235/26 , C07D239/80 , C07D265/36 , C07D285/14 , C07D285/22 , C07D307/79 , C07D311/58 , C07D319/18 , C07D333/22 , C07D471/06 , C07D513/06
CPC分类号: A61K31/00 , A61K31/138 , A61K31/40 , A61K31/445 , A61K31/473 , A61K31/549 , A61K31/55 , A61K31/553 , C07C233/41 , C07C311/07 , C07C311/08 , C07C311/37 , C07C2602/08 , C07D209/08 , C07D209/14 , C07D209/48 , C07D211/32 , C07D215/227 , C07D217/04 , C07D217/06 , C07D217/08 , C07D223/16 , C07D235/26 , C07D239/80 , C07D265/36 , C07D285/14 , C07D285/22 , C07D307/78 , C07D307/79 , C07D311/58 , C07D319/18 , C07D333/22 , C07D471/06 , C07D513/06 , G01N2333/91215
摘要: Preventives/remedies for voiding disturbance containing a compound having both of an acetylcholinesterase inhibitory action and an α1 antagonistic action which exhibits an excellent effect of improving the urinary function of the bladder (i.e., effects of improving urine flow rate and voiding efficiency) without affecting the urinary pressure or the blood pressure.
摘要翻译: 含有具有乙酰胆碱酯酶抑制作用的化合物和α1拮抗作用的化合物的预防/补救措施,其显示出改善膀胱尿功能的优异效果(即,改善尿流率和排尿效率的效果)而不影响 尿压或血压。
-
公开(公告)号:US07132547B2
公开(公告)日:2006-11-07
申请号:US10500217
申请日:2002-12-26
申请人: Yuji Ishihara , Yuji Ishichi , Takayuki Doi , Hiroshi Nagabukuro , Naoyuki Kanzaki , Motoki Ikeuchi
发明人: Yuji Ishihara , Yuji Ishichi , Takayuki Doi , Hiroshi Nagabukuro , Naoyuki Kanzaki , Motoki Ikeuchi
IPC分类号: C07D235/24
CPC分类号: A61K31/00 , A61K31/138 , A61K31/40 , A61K31/445 , A61K31/473 , A61K31/549 , A61K31/55 , A61K31/553 , C07C233/41 , C07C311/07 , C07C311/08 , C07C311/37 , C07C2602/08 , C07D209/08 , C07D209/14 , C07D209/48 , C07D211/32 , C07D215/227 , C07D217/04 , C07D217/06 , C07D217/08 , C07D223/16 , C07D235/26 , C07D239/80 , C07D265/36 , C07D285/14 , C07D285/22 , C07D307/78 , C07D307/79 , C07D311/58 , C07D319/18 , C07D333/22 , C07D471/06 , C07D513/06 , G01N2333/91215
摘要: Preventives/remedies for voiding disturbance containing a compound having both of an acetylcholinesterase inhibitory action and an α1 antagonistic action which exhibits an excellent effect of improving the urinary function of the bladder (i.e., effects of improving urine flow rate and voiding efficiency) without affecting the urinary pressure or the blood pressure.
-
公开(公告)号:US20060063769A1
公开(公告)日:2006-03-23
申请号:US10500217
申请日:2002-12-26
申请人: Yuji Ishihara , Yuji Ishichi , Takayuki Doi , Hiroshi Nagabukuro , Naoyuki Kanzaki , Motoki Ikeuchi
发明人: Yuji Ishihara , Yuji Ishichi , Takayuki Doi , Hiroshi Nagabukuro , Naoyuki Kanzaki , Motoki Ikeuchi
IPC分类号: A61K31/517 , A61K31/454
CPC分类号: A61K31/00 , A61K31/138 , A61K31/40 , A61K31/445 , A61K31/473 , A61K31/549 , A61K31/55 , A61K31/553 , C07C233/41 , C07C311/07 , C07C311/08 , C07C311/37 , C07C2602/08 , C07D209/08 , C07D209/14 , C07D209/48 , C07D211/32 , C07D215/227 , C07D217/04 , C07D217/06 , C07D217/08 , C07D223/16 , C07D235/26 , C07D239/80 , C07D265/36 , C07D285/14 , C07D285/22 , C07D307/78 , C07D307/79 , C07D311/58 , C07D319/18 , C07D333/22 , C07D471/06 , C07D513/06 , G01N2333/91215
摘要: Preventives/remedies for voiding disturbance containing a compound having both of an acetylcholinesterase inhibitory action and an α1 antagonistic action which exhibits an excellent effect of improving the urinary function of the bladder (i.e., effects of improving urine flow rate and voiding efficiency) without affecting the urinary pressure or the blood pressure.
摘要翻译: 含有具有乙酰胆碱酯酶抑制作用的化合物和α1拮抗作用的化合物的预防/补救措施,其显示出改善膀胱尿功能的优异效果(即,改善尿流率和排尿效率的效果)而不影响 尿压或血压。
-
公开(公告)号:US07462628B2
公开(公告)日:2008-12-09
申请号:US11333375
申请日:2006-01-18
申请人: Yuji Ishihara , Yuji Ishichi , Takayuki Doi , Hiroshi Nagabukuro , Naoyuki Kanzaki , Motoki Ikeuchi
发明人: Yuji Ishihara , Yuji Ishichi , Takayuki Doi , Hiroshi Nagabukuro , Naoyuki Kanzaki , Motoki Ikeuchi
IPC分类号: A61K31/44 , C07D451/00 , C07D453/00 , C07D455/00
CPC分类号: A61K31/00 , A61K31/138 , A61K31/40 , A61K31/445 , A61K31/473 , A61K31/549 , A61K31/55 , A61K31/553 , C07C233/41 , C07C311/07 , C07C311/08 , C07C311/37 , C07C2602/08 , C07D209/08 , C07D209/14 , C07D209/48 , C07D211/32 , C07D215/227 , C07D217/04 , C07D217/06 , C07D217/08 , C07D223/16 , C07D235/26 , C07D239/80 , C07D265/36 , C07D285/14 , C07D285/22 , C07D307/78 , C07D307/79 , C07D311/58 , C07D319/18 , C07D333/22 , C07D471/06 , C07D513/06 , G01N2333/91215
摘要: Preventives/remedies for voiding disturbance containing a compound having both of an acetylcholinesterase inhibitory action and an α1 antagonistic action which exhibits an excellent effect of improving the urinary function of the bladder (i.e., effects of improving urine flow rate and voiding efficiency) without affecting the urinary pressure or the blood pressure.
摘要翻译: 含有具有乙酰胆碱酯酶抑制作用的化合物和α1拮抗作用的化合物的预防/补救措施,其显示出改善膀胱尿功能的优异效果(即,改善尿流率和排尿效率的效果)而不影响 尿压或血压。
-
公开(公告)号:US07138533B2
公开(公告)日:2006-11-21
申请号:US10935646
申请日:2004-09-08
申请人: Yuji Ishihara , Yuji Ishichi , Takayuki Doi , Hiroshi Nagabukuro , Naoyuki Kanzaki , Motoki Ikeuchi
发明人: Yuji Ishihara , Yuji Ishichi , Takayuki Doi , Hiroshi Nagabukuro , Naoyuki Kanzaki , Motoki Ikeuchi
IPC分类号: C07D307/78 , C07D307/87 , C07D307/93
CPC分类号: A61K31/00 , A61K31/138 , A61K31/40 , A61K31/445 , A61K31/473 , A61K31/549 , A61K31/55 , A61K31/553 , C07C233/41 , C07C311/07 , C07C311/08 , C07C311/37 , C07C2602/08 , C07D209/08 , C07D209/14 , C07D209/48 , C07D211/32 , C07D215/227 , C07D217/04 , C07D217/06 , C07D217/08 , C07D223/16 , C07D235/26 , C07D239/80 , C07D265/36 , C07D285/14 , C07D285/22 , C07D307/78 , C07D307/79 , C07D311/58 , C07D319/18 , C07D333/22 , C07D471/06 , C07D513/06 , G01N2333/91215
摘要: Preventives/remedies for voiding disturbance containing a compound having both of an acetylcholinesterase inhibitory action and an α1 antagonistic action which exhibits an excellent effect of improving the urinary function of the bladder (i.e., effects of improving urine flow rate and voiding efficiency) without affecting the urinary pressure or the blood pressure.
-
-
-
-
-
-
-
-
-